Literature DB >> 24698019

Identification of functional visual field loss by automated static perimetry.

Lars Frisén1.   

Abstract

PURPOSE: Diagnosis of functional visual field loss, that is, field loss lacking objective corollaries, has long relied on kinetic visual field examinations using tangent screens or manual perimeters. The modern dominance of automated static perimeters requires the formulation of new diagnostic criteria.
METHODS: Retrospective review of automated perimetry records from 36 subjects meeting clinical and tangent screen criteria for functional visual field loss. Thirty-three normal eyes and 57 eyes with true lesions, including optic nerve compression, glaucoma, anterior ischaemic optic neuropathy and vigabatrin toxicity, served as controls.
RESULTS: Standard automated perimetry statistics were unable to reliably discriminate organic versus non-organic visual field loss. Subjective evaluation of perimetric maps indicated that functional fields generally could be identified by the presence of severe and irregular contractions and depressions that did not conform to the visual system's neuro-architecture. Further, functional fields generally presented one or more isolated threshold 'spikes', that is, isolated locations showing much better than average sensitivity. On repeated examinations, threshold spikes always changed locations. Visual evaluation for spikes proved superior to an objective computational algorithm. Fairly reliable objective discrimination of functional fields could be achieved by point-wise correlations of repeated examinations: median intertest correlation coefficients equalled 0.47 compared with 0.81 for true lesions.
CONCLUSION: Functional visual loss can be identified by automated static perimetry. Useful criteria include severe and irregular contractions and depressions, the presence of isolated threshold spikes and poor intertest correlations.
© 2014 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  functional visual field loss; optic nerve; perimetry; visual fields

Mesh:

Year:  2014        PMID: 24698019     DOI: 10.1111/aos.12405

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  3 in total

1.  Objective Derivation of the Morphology and Staging of Visual Field Loss Associated with Long-Term Vigabatrin Therapy.

Authors:  John M Wild; Philip E M Smith; Carlo Knupp
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

2.  MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Ayman Tourbah; Olivier Gout; Alain Vighetto; Véronique Deburghgraeve; Jean Pelletier; Caroline Papeix; Christine Lebrun-Frenay; Pierre Labauge; David Brassat; Ahmed Toosy; David-Axel Laplaud; Olivier Outteryck; Thibault Moreau; Marc Debouverie; Pierre Clavelou; Olivier Heinzlef; Jérôme De Sèze; Gilles Defer; Frédéric Sedel; Carl Arndt
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

Review 3.  Visual function tests for glaucoma practice - What is relevant?

Authors:  Aparna Rao; Debananda Padhy; Anindita Pal; Avik Kumar Roy
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.